{
"@context": "https://schema.org",
"@graph": [
{
"@type": "WebPage",
"@id": "https://www.fortrea.com/insights/transforming-long-term-fsp-partnership-enhance-global-oncology-studies#webpage",
"url": "https://www.fortrea.com/insights/transforming-long-term-fsp-partnership-enhance-global-oncology-studies",
"name": "Transforming a Long-Term FSP partnership to enhance global oncology studies",
"description": "This Fortrea case study explores how an FSP partnership for global oncology studies was implemented to support flexible resourcing and operational continuity across oncology clinical development activities. The study involved a biotechnology sponsor managing global oncology studies requiring scalable support across multiple operational and clinical development functions during ongoing trial activities. The case study highlights challenges related to oncology resource management, staffing flexibility, operational continuity, and coordination across global study teams throughout the clinical development lifecycle. Fortrea implemented an FSP partnership model to provide integrated oncology operational support, flexible clinical resourcing, and structured workforce management aligned with changing study demands and development timelines. By integrating flexible staffing support with global oncology operational management and clinical development coordination, the approach strengthened study continuity and supported execution across global oncology clinical trial activities."
},
{
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "Home",
"item": "https://www.fortrea.com"
},
{
"@type": "ListItem",
"position": 2,
"name": "Insights",
"item": "https://www.fortrea.com/insights/"
},
{
"@type": "ListItem",
"position": 3,
"name": "Transforming a Long-Term FSP partnership to enhance global oncology studies",
"item": "https://www.fortrea.com/insights/transforming-long-term-fsp-partnership-enhance-global-oncology-studies"
}
]
},
{
"@type": "Organization",
"@id": "https://www.fortrea.com/#organization",
"name": "Fortrea",
"url": "https://www.fortrea.com",
"description": "Fortrea is a global contract research organization built on more than 30 years of experience and one of the earliest CRO legacies in the industry—as Covance, evolving within Labcorp, and now operating as Fortrea. With deep expertise across Phase I–IV clinical trials, Fortrea advances clinical research through a patient-centric approach that prioritizes meaningful outcomes, stronger site–CRO relationships, and operational excellence. Fortrea partners with biopharmaceutical, biotech, and medical device companies to advance therapies through every stage of clinical development. This commitment is further reinforced by the launch of Fortrea Intelligent Technology, enabling smarter, more connected, and data-driven clinical development. Through Fortrea Intelligent Technology, the organization is advancing data-driven, technology-enabled clinical development to improve speed, quality, and patient outcomes. It is shaped by experience, innovation, and a commitment to raising standards in clinical research—focused on accelerating development and helping bring life-changing treatments to patients around the world.",
"logo": "https://www.fortrea.com/sites/default/files/2025-05/fortrea-logo-without-background.png",
"sameAs": [
"https://www.linkedin.com/company/fortrea",
"https://www.threads.net/@fortreacro",
"https://twitter.com/fortrea",
"https://www.youtube.com/@Fortrea/",
"https://www.facebook.com/Fortrea-104143099267108",
"https://www.instagram.com/fortreacro"
]
},
{
"@type": "Article",
"@id": "https://www.fortrea.com/insights/transforming-long-term-fsp-partnership-enhance-global-oncology-studies#casestudy",
"mainEntityOfPage": {
"@id": "https://www.fortrea.com/insights/transforming-long-term-fsp-partnership-enhance-global-oncology-studies#webpage"
},
"headline": "Enhancing Global Oncology Studies Through an FSP Partnership Model | Fortrea Case Study",
"description": "This Fortrea case study explores how an FSP partnership for global oncology studies was implemented to support flexible resourcing and operational continuity across oncology clinical development activities. The study involved a biotechnology sponsor managing global oncology studies requiring scalable support across multiple operational and clinical development functions during ongoing trial activities. The case study highlights challenges related to oncology resource management, staffing flexibility, operational continuity, and coordination across global study teams throughout the clinical development lifecycle. Fortrea implemented an FSP partnership model to provide integrated oncology operational support, flexible clinical resourcing, and structured workforce management aligned with changing study demands and development timelines. By integrating flexible staffing support with global oncology operational management and clinical development coordination, the approach strengthened study continuity and supported execution across global oncology clinical trial activities.",
"genre": "Case Study",
"image": {
"@type": "ImageObject",
"url": "https://www.fortrea.com/sites/default/files/2025-04/fsp-partnership-to-enhance-global-oncology-studies.jpg"
},
"author": {
"@type": "Organization",
"name": "Fortrea",
"url": "https://www.fortrea.com/"
},
"publisher": {
"@id": "https://www.fortrea.com/#organization"
},
"datePublished": "2025-04-03",
"dateModified": "2025-04-03",
"encoding": {
"@type": "MediaObject",
"contentUrl": "https://www.fortrea.com/sites/default/files/2025-04/fsp-partnership-to-enhance-global-oncology-studies.pdf",
"encodingFormat": "application/pdf"
}
}
]
}